Combined Bilateral Salpingo-oophorectomy and Cesarean Delivery in BRCA1/2 Alteration Carriers: A Case Series

被引:1
|
作者
Barker, Victoria E. [1 ,2 ]
Vlachodimitropoulou, Evangelia [1 ,2 ]
O'Brien, Patrick [1 ,2 ]
Iskaros, Joseph [1 ,2 ]
Rosenthal, Adam N. [1 ,2 ,3 ]
机构
[1] Univ Coll London Hosp, Natl Hlth Serv Fdn Trust, London, England
[2] UCL, Univ Coll London Elizabeth Garrett Anderson Inst W, Dept Womens Canc, London, England
[3] Univ Coll London Hosp NHS Fdn Trust, London, England
关键词
BREAST-CANCER; OVARIAN; RISK; WOMEN;
D O I
10.1097/AOG.0000000000005423
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: The cumulative lifetime risk of ovarian cancer is 16-68% and 11-30% in female BRCA1 and BRCA2 gene alteration carriers, respectively. Risk-reducing bilateral salpingo-oophorectomy (RRSO) is the only proven way to reduce ovarian cancer mortality. We report a series of patients who underwent risk-reducing surgery at the time of planned obstetric-indicated cesarean delivery.CASES: This is a case series of four women carrying a pathogenic germline BRCA1 or BRCA2 gene alteration who underwent RRSO at the time of cesarean delivery between March 1, 2018, and March 31, 2022. All women were referred during pregnancy to the University College London Hospitals Familial Cancer Clinic for consideration of RRSO at the time of obstetric-indicated cesarean delivery. Women were considered eligible for RRSO if they had a proven pathogenic germline alteration, would have completed childbearing after the cesarean delivery, and were older than age 35 or 40 years with BRCA1 or BRCA2 alterations, respectively. Operating time, blood loss, transfusion requirements, length of hospital stay, complications, and ability to breastfeed were assessed and, where possible, compared with the institutional means for similar patients who underwent cesarean delivery only, to determine whether RRSO was associated with increased morbidity. Women were contacted 11-59 months postprocedure to assess satisfaction. The mean blood loss was 687 mL (range 400-1,000 mL), mean operating time was 68 minutes, mean length of hospital stay was 3 days, and mean change in hemoglobin was -1 g/dL. No patient required a transfusion, had internal organ damage, returned to the operating room, or was readmitted. One of two women with intact breast tissue successfully breastfed, and the other chose to bottle feed. The mean contemporaneous institutional blood loss for cesarean delivery was not significantly different at 681 mL for singleton pregnancies and 872 mL for twin pregnancies. All four women reported a high level of satisfaction with the combined procedure.CONCLUSION: Our results show that RRSO can be performed at the time of cesarean delivery with high patient satisfaction. This approach can be offered to appropriately counseled individuals, with the benefit of avoiding the need for two separate procedures, with potentially reduced patient morbidity and health care costs.
引用
收藏
页码:1500 / 1503
页数:4
相关论文
共 50 条
  • [41] Uptake Rate of Risk-Reducing Salpingo-Oophorectomy and Surgical Outcomes of Female Germline BRCA1/2 Mutation Carriers: A Retrospective Cohort Study
    Lim, Hyunji
    Kim, Se Ik
    Hyun, Sowoon
    Lee, Gwang Bin
    Seol, Aeran
    Lee, Maria
    YONSEI MEDICAL JOURNAL, 2021, 62 (12) : 1090 - 1097
  • [42] Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
    Rebbeck, Timothy R.
    Kauff, Noah D.
    Domchek, Susan M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (02): : 80 - 87
  • [43] Study on the psychosocial aspects of risk-reducing salpingo-oophorectomy (RRSO) in BRCA1/2 mutation carriers in Japan: a preliminary report
    Shigehiro, Mika
    Kita, Mizuho
    Takeuchi, Sayoko
    Ashihara, Yuumi
    Arai, Masami
    Okamura, Hitoshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (03) : 254 - 259
  • [44] Very high uptake of risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers: A single-center experience
    Harmsen, M. G.
    Arts-de Jong, M.
    Horstik, K.
    Manders, P.
    Massuger, L. F. A. G.
    Hermens, R. P. M. G.
    Hoogerbrugge, N.
    Woldringh, G. H.
    de Hullu, J. A.
    GYNECOLOGIC ONCOLOGY, 2016, 143 (01) : 113 - 119
  • [45] Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1 and BRCA2 mutations
    Smith, Maria J.
    Gerber, Deanna
    Olsen, Anne
    Khouri, Olivia R.
    Wang, Yuyan
    Liu, Mengling
    Smith, Julia
    Pothuri, Bhavana
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 225 (05)
  • [46] The impact of risk reducing bilateral salpingo-oophorectomy on sexual function in BRCA1/2 mutation carriers and women with Lynch syndrome: A systematic review and meta-analysis
    Kershaw, Victoria
    Hickey, India
    Wyld, Lynda
    Jha, Swati
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2021, 265 : 7 - 17
  • [47] Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
    Kotsopoulos, Joanne
    Huzarski, Tomasz
    Gronwald, Jacek
    Singer, Christian F.
    Moller, Pal
    Lynch, Henry T.
    Armel, Susan
    Karlan, Beth
    Foulkes, William D.
    Neuhausen, Susan L.
    Senter, Leigha
    Tung, Nadine
    Weitzel, Jeffrey N.
    Eisen, Andrea
    Metcalfe, Kelly
    Eng, Charis
    Pal, Tuya
    Evans, Gareth
    Sun, Ping
    Lubinski, Jan
    Narod, Steven A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (01):
  • [48] Use of total abdominal hysterectomy and hormone replacement therapy in BRCA1 and BRCA2 mutation carriers undergoing risk-reducing salpingo-oophorectomy
    Gabriel, C. A.
    Tigges-Cardwell, J.
    Stopfer, J.
    Erlichman, J.
    Nathanson, K.
    Domchek, S. M.
    FAMILIAL CANCER, 2009, 8 (01) : 23 - 28
  • [49] Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
    Nasim Mavaddat
    Antonis C. Antoniou
    Thea M. Mooij
    Maartje J. Hooning
    Bernadette A. Heemskerk-Gerritsen
    Catherine Noguès
    Marion Gauthier-Villars
    Olivier Caron
    Paul Gesta
    Pascal Pujol
    Alain Lortholary
    Daniel Barrowdale
    Debra Frost
    D. Gareth Evans
    Louise Izatt
    Julian Adlard
    Ros Eeles
    Carole Brewer
    Marc Tischkowitz
    Alex Henderson
    Jackie Cook
    Diana Eccles
    Klaartje van Engelen
    Marian J. E. Mourits
    Margreet G. E. M. Ausems
    Linetta B. Koppert
    John L. Hopper
    Esther M. John
    Wendy K. Chung
    Irene L. Andrulis
    Mary B. Daly
    Saundra S. Buys
    Javier Benitez
    Trinidad Caldes
    Anna Jakubowska
    Jacques Simard
    Christian F. Singer
    Yen Tan
    Edith Olah
    Marie Navratilova
    Lenka Foretova
    Anne-Marie Gerdes
    Marie-José Roos-Blom
    Flora E. Van Leeuwen
    Brita Arver
    Håkan Olsson
    Rita K. Schmutzler
    Christoph Engel
    Karin Kast
    Kelly-Anne Phillips
    Breast Cancer Research, 22
  • [50] Retrospective evaluation of risk-reducing salpingo-oophorectomy for BRCA1/2 pathogenic variant carriers among a cohort study in a single institution
    Kobayashi, Yusuke
    Hirasawa, Akira
    Chiyoda, Tatsuyuki
    Ueki, Arisa
    Masuda, Kenta
    Misu, Kumiko
    Kawaida, Miho
    Hayashi, Shigenori
    Kataoka, Fumio
    Banno, Kouji
    Kosaki, Kenjiro
    Aoki, Daisuke
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (02) : 213 - 217